19 June 2003




		National Institutes of Health

[Entry Page]
[11 Mar 2004]
[10 Mar 2004]
[9 Mar 2004]
[4 Dec 2003]
[3 Dec 2003]
[17 Oct 2003]
[17 Sept 2003]
[19 June 2003]
[18 June 2003]
[6-7 Mar 2003]
[4-6 Dec 2002]
[20-21 June 2002]
[7-8 Mar 2002]
[7-8 Dec 2001]
[06 Dec 2001]


	NATIONAL INSTITUTES OF HEALTH Recombinant DNA Advisory Committee (RAC) 91st Meeting of the NIH RAC Bethesda Marriot Hotel Bethesda, Maryland June 18-19 2003 Thursday, June 19, 2003 Powerpoint Slides 588 Carter Powerpoint Slides 588 Evans Powerpoint Slides 588 TNFR RAC Pub Powerpoint Slides 594 Carter Powerpoint Slides 594 Tissue Gene 8.30 AM Call to Order and Opening Remarks Theodore Friedmann, M.D., Chair, NIH RAC 8:35 AM Informed Consent What Consent Forms Say and What Researchers and Subjects Expect in Gene Therapy Research Nancy M.P. King, J.D., and Gail Henderson, Ph.D., University of North Carolina, Chapel Hill Powerpoint Slides 9:35 AM Discussion 9:50 AM BREAK 10:05 AM NIH RAC Informed Consent Working Group (ICWG) Drraft Guidance Nancy M.P. King, J.D., and Baruch Brody, Ph.D., Cochairs, ICWG Tab 2304 RAC ICWG Members: James Childress, Ph.D. Bernard Lo, M.D. Diane Wara, M.D. U.S. Department of Health and Human Services (DHHS) ICWG Members: Suzanne Goodwin, OBA Allan Shipp, OBA Stephen Rose, Ph.D., OBA Kristina Borror, Ph.D., Office for Human Research Protections, DHHS Cynthia Rask, M.D., U.S. Food and Drug Administration 10:35 AM Discussion 11:35 AM Public Comment 12:00 NOON ADJOURNMENT

		This webcast produced by